tert-Butyl N-{[4-(hydroxymethyl)oxan-4-yl]methyl}carbamate

Catalog No. :
ACAQFO329
CAS No. :
1311369-28-4
Molecular Formula :
C12H23NO4
Molecular Weight :
245.32

IUPAC Name:tert-butyl ((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)carbamate

tert-Butyl N-{[4-(hydroxymethyl)oxan-4-yl]methyl}carbamate structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
50mg97%$111.00Login to see priceInquiryInquiry
100mg97%$156.00Login to see priceInquiryInquiry
250mg97%$217.00Login to see priceInquiryInquiry
1g97%$417.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Nametert-Butyl N-{[4-(hydroxymethyl)oxan-4-yl]methyl}carbamate
IUPAC Nametert-butyl ((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)carbamate
Molecular FormulaC12H23NO4
Molecular Weight245.32
SMILESO=C(OC(C)(C)C)NCC1(CO)CCOCC1
InChI KeyRGLFDWZOPHOOEC-UHFFFAOYSA-N
Synonymtert-butyl ((4-(hydroxymethyl)tetrahydro-2H-pyran-4-yl)methyl)carbamate;tert-butyl tetrahydro-4-(hydroxymethyl)-2H-pyran-4-ylmethylcarbamate;4-[(Boc-amino)methyl]tetrahydropyran-4-methanol;tert-butyl N-{[4-(hydroxymethyl)oxan-4-yl]methyl}carbamate
CAS No.1311369-28-4

Safety Data

Pictogram
Harmful or irritant
Signal Word
Warning
Hazard Statement(s)
H302-H315-H319-H335
Precautionary Statement(s)
P261-P280-P301+P312-P302+P352-P305+P351+P338

Synthetic Route by SureRoute

1. ACAQFO329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACAQFO329 route product structure diagram
    ACAQFO3291311369-28-4
Inquiry

2. ACAQFO329 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Then
  3. ACAQFO329 route product structure diagram
    ACAQFO3291311369-28-4
Inquiry

Comments (0)